Are peptides legal in United Kingdom?
The short answer
In the United Kingdom, the licensed GLP-1 medicines semaglutide, tirzepatide and liraglutide are prescription only medicines that can only be prescribed by a healthcare professional, and the MHRA says the only way to be sure of a genuine product is a legitimate pharmacy with a prescription. Retatrutide has not been approved for UK use, and the MHRA says that outside authorised clinical trials any products sold in the UK claiming to contain it are likely to be illegal. Peptides used in cosmetics are covered by the cosmetic products rules, and peptide hormones are prohibited at all times in sport.
Status by category
| Category | Status |
|---|---|
| Approved peptide medicines | Prescription only |
| Research peptides | Unclear |
| Compounded preparations | Restricted |
| Cosmetics | Restricted |
| Food supplements | Unclear |
| Personal import | Restricted |
| Sport and anti-doping | Prohibited |
Approved peptide medicines Prescription only
The MHRA lists semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Mounjaro) and liraglutide as licensed GLP-1 medicines in the UK. All of them are prescription only medicines, so they can only be prescribed by a healthcare professional, and the MHRA says the only way to be sure of a genuine product is a legitimate pharmacy with a prescription. Advertising a prescription only medicine to the public is not permitted. [1][2]
Research peptides Unclear
No specific official rule found.
Compounded preparations Restricted
Unlicensed medicines, also called specials, have no UK marketing authorisation and may not have been assessed by the MHRA. Regulation 167 of the Human Medicines Regulations 2012 allows them to be supplied when no licensed medicine can meet the needs of an individual patient, and they must be specially manufactured or imported after an order by a prescriber such as a doctor or pharmacist independent prescriber. Home Office guidance confirms that medicines not licensed in the UK can still be prescribed by a UK clinician and made available as specials. [3][7]
Cosmetics Restricted
Cosmetic products available to consumers in Great Britain are covered by the cosmetic products rules. Every product must have a Responsible Person, must be safe for human health, and must be notified to the Office for Product Safety and Standards before it is made available. Individual ingredients may be prohibited or restricted in use under those rules. [8]
Food supplements Unclear
No specific official rule found.
Personal import Restricted
Home Office personal import policy covers medicines containing controlled drugs carried on the traveller, up to a three month supply of schedule 2 to 4 (part I) products that were lawfully prescribed in the traveller's country of habitual residence. The policy does not apply to people habitually resident in the UK who receive medical treatment abroad, and such medicines cannot be posted from overseas. For a medicine that does not contain a controlled drug, the guidance directs travellers to check the import rules with the MHRA. [7]
Sport and anti-doping Prohibited
UK Anti-Doping applies the WADA Prohibited List, which sets out the substances and methods prohibited in sport. Peptide hormones are given as an example of substances prohibited at all times. The List also states that substances with a similar chemical structure or similar biological effect are prohibited even when not named, and it is updated each year with effect from 1 January. [6]
Peptide by peptide
| Peptide | Status | Details |
|---|---|---|
| semaglutide | Prescription only | Semaglutide is licensed in the UK under the brands Wegovy, Ozempic and Rybelsus and, like all GLP-1 medicines, is a prescription only medicine. [1] |
| tirzepatide | Prescription only | Tirzepatide (Mounjaro) is a licensed UK GLP-1 medicine and is prescription only, and the MHRA has seized unlicensed tirzepatide pens from an illicit production site. [1][4] |
| retatrutide | Not authorised | Retatrutide is in clinical development and has not been approved for UK use, so products sold in the UK claiming to contain it are likely to be illegal outside authorised clinical trials. [4] |
Change history
- The Home Office updated its guidance on travelling with medicine containing controlled drugs, including a change of the page title. [7]
- The MHRA announced the dismantling of an illicit weight loss medicine production facility in Northampton, seizing more than 2,000 unlicensed retatrutide and tirzepatide pens, and restated that retatrutide is not approved for UK use. [4]
- The WADA Prohibited List applied by UK Anti-Doping is updated every year and the new version takes effect on 1 January, so the 2026 List with its summary of changes replaced the previous one. [6]
- The MHRA, the Advertising Standards Authority and the General Pharmaceutical Council issued a joint warning against promoting newly licensed prescription only medicines and products with no marketing authorisation, including pipeline weight management products and waiting lists for them. [2]
Official sources
- GLP-1 medicines for weight loss and diabetes: what you need to know, Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK
- Warning on promoting newly licensed prescription-only medicines and unlicensed medicines for weight management, MHRA, Advertising Standards Authority and General Pharmaceutical Council, GOV.UK
- Supply unlicensed medicinal products ("specials"), MHRA, GOV.UK
- MHRA smashes major illicit weight loss medicine production facility in record seizure, MHRA, GOV.UK
- Major Changes to the 2022 Prohibited List: What you need to know (BPC-157 added as prohibited substance), UK Anti-Doping (UKAD)
- What's banned in sport - the Prohibited List, UK Anti-Doping (UKAD)
- Travelling with medicine containing controlled drugs (personal import policy), Home Office, GOV.UK
- Making cosmetic products available to consumers in Great Britain, Office for Product Safety and Standards (OPSS), GOV.UK
General information, not legal advice. Rules change: check the official source before you act.